Renal tubulointerstitial lesions: a prognostic marker in idiopathic membranous nephropathy [PDF]
Renal FailureObjective To evaluate the impact of renal tubulointerstitial lesions (TIL) on clinical and pathologic outcomes and prognosis in patients with idiopathic membranous nephropathy.Methods A retrospective cohort study was performed on 582 patients with ...
Yonghua Liu +3 more
doaj +3 more sources
Renal Failure, 2022 Objectives Idiopathic membranous nephropathy (iMN) is a major cause of nephrotic syndrome. Atypical membranous nephropathy (aMN) is a new type of nephropathy in China, characterized by a ‘full-house’ on immunofluorescent examination, that is IgG, IgA ...
Yu Yan, Li Zuo
exaly +4 more sources
Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy [PDF]
Renal Failure, 2023 Background Idiopathic membranous nephropathy (IMN) is the leading cause of nephrotic syndrome in the elderly. The treatment of idiopathic membranous nephropathy is quite challenging due to the particularity of elderly patients.
Wenke Hao, Wenxue Hu
exaly +3 more sources
Randomised, double-blind study to evaluate the efficacy of rituximab in the treatment of idiopathic membranous nephropathy: A clinical trial protocol. [PDF]
PLoS ONEIn Japan, corticosteroid monotherapy has traditionally been recommended as the first-line therapy for membranous nephropathy with nephrotic syndrome.
Shinobu Shimizu +6 more
doaj +2 more sources
Single‐dose telitacicept therapy for refractory idiopathic membranous nephropathy: A case series [PDF]
Clinical Case ReportsKey Clinical Message We report three cases of IMN from our center, where patients received a single dose of telitacicept after showing no response to conventional treatments.
Liping Sun, Fuce Chen, Xinzhou Zhang
doaj +2 more sources
Telitacicept monotherapy for refractory idiopathic membranous nephropathy: a case report and literature review [PDF]
Frontiers in MedicineBackgroundPatients with refractory membranous nephropathy (MN) face risks of progressive renal decline and end-stage renal disease (ESRD), with limited treatment efficacy.
Shucheng Chen, Yiqi Huang, Zhongjie Qu
doaj +2 more sources
Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more [PDF]
Journal of Nephropathology, 2018 Context: Membranous nephropathy is among the most common causes of nephrotic syndrome in adults. Evidence Acquisitions: PubMed, EBSCO, Web of Science, directory of open access journals (DOAJ), EMBASE, and Google Scholar with keywords of phospholipase A2 ...
Bahar Bastani
doaj +1 more source
Frontiers in Pharmacology, 2022 The coexistence of anti-glomerular basement membrane (GBM) disease, idiopathic membranous nephropathy (IMN), and IgA nephropathy in one patient is a very rare case, which has not yet been reported.
Wei Qu +7 more
doaj +1 more source
Penicillamine-Induced Membranous Nephropathy in an Adolescent with Wilson’s Disease [PDF]
Revista Portuguesa de Nefrologia e Hipertensão, 2022 Membranous nephropathy may present in any age group. While it is one of the most common causes of adult nephrotic syndrome, it is a rare histologic entity in the paediatric population.
Catarina Fernandes +5 more
doaj +1 more source
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy [PDF]
, 2016 Membranous nephropathy (MN), a major cause of nephrotic syndrome, is a non-inflammatory immune kidney disease mediated by IgG antibodies that form glomerular subepithelial immune complexes.
Dorin-Bogdan Borza
core +4 more sources